Literature DB >> 22143875

Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae.

A Gorlani1, D Lutje Hulsik, H Adams, G Vriend, P Hermans, T Verrips.   

Abstract

Variable domains of llama heavy-chain antibodies (VHH) are becoming a potent tool for a wide range of biotechnological and medical applications. Because of structural features typical of their single-domain nature, they are relatively easy to produce in lower eukaryotes, but it is not uncommon that some molecules have poor secretion efficiency. We therefore set out to study the production yield of VHH. We computationally identified five key residues that are crucial for folding and secretion, and we validated their importance with systematic site-directed mutations. The observation that all key residues were localised in the V segment, in proximity of the J segment of VHH, led us to study the importance of J segment in secretion efficiency. Intriguingly, we found that the use of specific J segments in VHH could strongly influence the production yield. Sequence analysis and expression experiments strongly suggested that interactions with chaperones, especially with the J segment, are a crucial aspect of the production yield of VHH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22143875     DOI: 10.1093/protein/gzr057

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  8 in total

1.  A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.

Authors:  Davide Ferrari; Valentina Garrapa; Massimo Locatelli; Angelo Bolchi
Journal:  Mol Biotechnol       Date:  2020-01       Impact factor: 2.695

2.  Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification.

Authors:  Vida Mashayekhi; Erik Schooten; Paul M P van Bergen En Henegouwen; Marta M Kijanka; Sabrina Oliveira
Journal:  Methods Mol Biol       Date:  2022

3.  Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.

Authors:  Angela I Schriek; Marlies M van Haaren; Meliawati Poniman; Gillian Dekkers; Arthur E H Bentlage; Marloes Grobben; Gestur Vidarsson; Rogier W Sanders; Theo Verrips; Teunis B H Geijtenbeek; Raimond Heukers; Neeltje A Kootstra; Steven W de Taeye; Marit J van Gils
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

4.  Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.

Authors:  Kasper Krogh Andersen; Nika M Strokappe; Anna Hultberg; Kai Truusalu; Imbi Smidt; Raik-Hiio Mikelsaar; Marika Mikelsaar; Theo Verrips; Lennart Hammarström; Harold Marcotte
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

Review 5.  VHH antibodies: emerging reagents for the analysis of environmental chemicals.

Authors:  Candace S Bever; Jie-Xian Dong; Natalia Vasylieva; Bogdan Barnych; Yongliang Cui; Zhen-Lin Xu; Bruce D Hammock; Shirley J Gee
Journal:  Anal Bioanal Chem       Date:  2016-05-21       Impact factor: 4.142

6.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

Review 7.  Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2015-09-02       Impact factor: 5.328

8.  Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.

Authors:  Dae Young Kim; Rebecca To; Hiba Kandalaft; Wen Ding; Henk van Faassen; Yan Luo; Joseph D Schrag; Nadereh St-Amant; Mary Hefford; Tomoko Hirama; John F Kelly; Roger MacKenzie; Jamshid Tanha
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.